Antibodies to amino acid 200-239 (p200) of Ro52 as serological markers for the risk of developing congenital heart block.
about
Congenital heart block maternal sera autoantibodies target an extracellular epitope on the α1G T-type calcium channel in human fetal hearts.Detection of autoantibodies in a point-of-care rheumatology setting.Umbilical cord blood levels of maternal antibodies reactive with p200 and full-length Ro 52 in the assessment of risk for cardiac manifestations of neonatal lupus.Congenital heart block: evidence for a pathogenic role of maternal autoantibodiesAssociation of the idiotype:antiidiotype antibody ratio with the efficacy of intravenous immunoglobulin treatment for the prevention of recurrent autoimmune-associated congenital heart block.Pregnancy outcomes in patients with autoimmune diseases and anti-Ro/SSA antibodies.Maternal autoantibody profiles at risk for autoimmune congenital heart block: a prospective study in high-risk patients.In search of an antibody specificity highly predictive of congenital heart block.Recurrence rates of cardiac manifestations associated with neonatal lupus and maternal/fetal risk factors.Cutaneous lupus in infancy and childhood.The clinical spectrum of autoimmune congenital heart block.Autoimmune congenital heart block: complex and unusual situations.Progress in the pathogenesis and treatment of cardiac manifestations of neonatal lupus.Congenital heart block and immune mediated sensorineural hearing loss: possible cross reactivity of immune response.Induction of autoimmune response to the extracellular loop of the HERG channel pore induces QTc prolongation in guinea-pigs.A population-based investigation of the autoantibody profile in mothers of children with atrioventricular block.Anti-Ro52 antibody level is an important marker of fetal congenital heart block risk in anti-Ro/SSA antibody positive pregnancy.The high incidence of anti-Ro/SSA and anti-p200 antibodies in female patients with connective tissue diseases confirms the importance of screening for congenital heart block-associated autoantibodies during pregnancy.The HLA locus contains novel foetal susceptibility alleles for congenital heart block with significant paternal influence
P2860
Q34988528-402D6E82-6E08-4E56-82DC-8D405365DF9AQ35309576-F6B8F017-A53B-4035-A03F-5D2223C11F0DQ36146961-47183C68-4DB5-4837-87A7-6DB90A6769B4Q36245765-57CAF559-8779-491D-92CF-1460C24ECA65Q36551060-252E76AF-8F06-48B4-AAEB-CB1D91789327Q36570988-B50A17B4-9803-443D-9B32-71C4910FA766Q36733075-F4B4B089-785D-4DB5-9738-CC5336227482Q36861492-F25D6D6B-F8A0-4C80-A847-8A98D90FBECCQ37393128-C3AE8EBE-8459-4FEC-AF73-F30083F63B66Q37778651-82B6A822-6EDB-4B7D-B800-B43F08752CC4Q38387739-8E8B04AA-706B-42CA-B189-036970051C49Q38695221-B4778B01-7267-46EA-AD32-FC0CB428402FQ38777181-083F765E-8412-411D-AFAF-5698B3EB404CQ39134569-6E712416-6A5C-43B6-971A-E1C158CD32E8Q39686708-657A15B3-C830-469A-9F05-C1D4BDF390C1Q44355666-E4AFDEA6-31DD-422D-88C0-D4A63343EFADQ50207083-2DF009C1-D879-4D62-9AF3-D677508A889BQ50936149-38D526AE-7FEA-43D8-8D27-2FBD91B9F62DQ57224126-6099477A-6790-4051-9F7E-C385163608FE
P2860
Antibodies to amino acid 200-239 (p200) of Ro52 as serological markers for the risk of developing congenital heart block.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Antibodies to amino acid 200-2 ...... loping congenital heart block.
@en
Antibodies to amino acid 200-239
@nl
type
label
Antibodies to amino acid 200-2 ...... loping congenital heart block.
@en
Antibodies to amino acid 200-239
@nl
prefLabel
Antibodies to amino acid 200-2 ...... loping congenital heart block.
@en
Antibodies to amino acid 200-239
@nl
P2093
P2860
P1476
Antibodies to amino acid 200-2 ...... loping congenital heart block.
@en
P2093
H Julkunen
L Strandberg
O Winqvist
S Salomonsson
S-E Sonesson
P2860
P356
10.1111/J.1365-2249.2008.03732.X
P577
2008-08-22T00:00:00Z